• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Tau 导致 P301L 转基因小鼠和人类阿尔茨海默病的血管异常和血管生成相关基因表达。

Tau induces blood vessel abnormalities and angiogenesis-related gene expression in P301L transgenic mice and human Alzheimer's disease.

机构信息

Department of Neurology, MassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129.

Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA 02115.

出版信息

Proc Natl Acad Sci U S A. 2018 Feb 6;115(6):E1289-E1298. doi: 10.1073/pnas.1710329115. Epub 2018 Jan 22.

DOI:10.1073/pnas.1710329115
PMID:29358399
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5819390/
Abstract

Mixed pathology, with both Alzheimer's disease and vascular abnormalities, is the most common cause of clinical dementia in the elderly. While usually thought to be concurrent diseases, the fact that changes in cerebral blood flow are a prominent early and persistent alteration in Alzheimer's disease raises the possibility that vascular alterations and Alzheimer pathology are more directly linked. Here, we report that aged tau-overexpressing mice develop changes to blood vessels including abnormal, spiraling morphologies; reduced blood vessel diameters; and increased overall blood vessel density in cortex. Blood flow in these vessels was altered, with periods of obstructed flow rarely observed in normal capillaries. These changes were accompanied by cortical atrophy as well as increased expression of angiogenesis-related genes such as , , and in CD31-positive endothelial cells. Interestingly, mice overexpressing nonmutant forms of tau in the absence of frank neurodegeneration also demonstrated similar changes. Furthermore, many of the genes we observe in mice are also altered in human RNA datasets from Alzheimer patients, particularly in brain regions classically associated with tau pathology such as the temporal lobe and limbic system regions. Together these data indicate that tau pathological changes in neurons can impact brain endothelial cell biology, altering the integrity of the brain's microvasculature.

摘要

混合病理学,既有阿尔茨海默病又有血管异常,是老年人临床痴呆最常见的原因。虽然通常认为这是两种并存的疾病,但阿尔茨海默病中脑血流变化是早期和持续存在的突出改变这一事实,使得血管改变和阿尔茨海默病病理学之间的联系更加紧密。在这里,我们报告说,衰老的过度表达 tau 的小鼠会发生血管变化,包括异常的螺旋形态;血管直径减小;大脑皮层中的总血管密度增加。这些血管中的血流发生了改变,在正常毛细血管中很少观察到血流阻塞的时期。这些变化伴随着皮质萎缩,以及血管生成相关基因的表达增加,如在 CD31 阳性内皮细胞中表达的 、 和 。有趣的是,即使没有明显的神经退行性变,过度表达非突变形式 tau 的小鼠也表现出类似的变化。此外,我们在小鼠中观察到的许多基因也在阿尔茨海默病患者的人类 RNA 数据集发生改变,特别是在与 tau 病理学相关的大脑区域,如颞叶和边缘系统区域。这些数据表明,神经元中的 tau 病理变化会影响脑内皮细胞生物学,改变大脑微血管的完整性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d99/5819390/a83af98d0c6f/pnas.1710329115fig06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d99/5819390/2b48ee6f39ea/pnas.1710329115fig01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d99/5819390/2db63e888fed/pnas.1710329115fig02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d99/5819390/490e2031b112/pnas.1710329115fig03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d99/5819390/5e4d45ccb2cd/pnas.1710329115fig04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d99/5819390/d307e21fc3de/pnas.1710329115fig05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d99/5819390/a83af98d0c6f/pnas.1710329115fig06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d99/5819390/2b48ee6f39ea/pnas.1710329115fig01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d99/5819390/2db63e888fed/pnas.1710329115fig02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d99/5819390/490e2031b112/pnas.1710329115fig03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d99/5819390/5e4d45ccb2cd/pnas.1710329115fig04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d99/5819390/d307e21fc3de/pnas.1710329115fig05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d99/5819390/a83af98d0c6f/pnas.1710329115fig06.jpg

相似文献

1
Tau induces blood vessel abnormalities and angiogenesis-related gene expression in P301L transgenic mice and human Alzheimer's disease.Tau 导致 P301L 转基因小鼠和人类阿尔茨海默病的血管异常和血管生成相关基因表达。
Proc Natl Acad Sci U S A. 2018 Feb 6;115(6):E1289-E1298. doi: 10.1073/pnas.1710329115. Epub 2018 Jan 22.
2
Acyl-coenzyme A:cholesterol acyltransferase 1 blockage enhances autophagy in the neurons of triple transgenic Alzheimer's disease mouse and reduces human P301L-tau content at the presymptomatic stage.酰基辅酶A:胆固醇酰基转移酶1阻断增强三重转基因阿尔茨海默病小鼠神经元中的自噬,并在症状前期降低人P301L- tau蛋白含量。
Neurobiol Aging. 2015 Jul;36(7):2248-2259. doi: 10.1016/j.neurobiolaging.2015.04.002. Epub 2015 Apr 7.
3
Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.泛素结合酶 1 在人类阿尔茨海默病和 APP/PS1 转基因小鼠脑及基于细胞模型中的关系。
Neurobiol Dis. 2016 Jan;85:187-205. doi: 10.1016/j.nbd.2015.11.005. Epub 2015 Nov 10.
4
Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.α1-抗糜蛋白酶是一种在阿尔茨海默病大脑中过度表达的炎症蛋白,可诱导神经元中的tau蛋白磷酸化。
Brain. 2006 Nov;129(Pt 11):3020-34. doi: 10.1093/brain/awl255. Epub 2006 Sep 20.
5
Accelerated tau pathology with synaptic and neuronal loss in a novel triple transgenic mouse model of Alzheimer's disease.阿尔茨海默病新型三转基因小鼠模型中tau 蛋白病理加速伴突触和神经元丢失。
Neurobiol Aging. 2013 Nov;34(11):2564-73. doi: 10.1016/j.neurobiolaging.2013.05.003. Epub 2013 Jun 5.
6
Sex Dimorphism Profile of Alzheimer's Disease-Type Pathologies in an APP/PS1 Mouse Model.APP/PS1小鼠模型中阿尔茨海默病型病理的性别二态性特征
Neurotox Res. 2016 Feb;29(2):256-66. doi: 10.1007/s12640-015-9589-x. Epub 2015 Dec 26.
7
The GABAergic septohippocampal connection is impaired in a mouse model of tauopathy.在tau蛋白病小鼠模型中,γ-氨基丁酸能的隔海马连接受损。
Neurobiol Aging. 2017 Jan;49:40-51. doi: 10.1016/j.neurobiolaging.2016.09.006. Epub 2016 Sep 15.
8
Reduction of the cerebrovascular volume in a transgenic mouse model of Alzheimer's disease.阿尔茨海默病转基因小鼠模型中脑血管体积的减少
Neuropharmacology. 2009 Mar;56(4):808-13. doi: 10.1016/j.neuropharm.2009.01.006.
9
Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.源自散发性阿尔茨海默病 iPSC 的神经元显示出 TAU 过度磷酸化增加、淀粉样蛋白水平升高和 GSK3β 激活。
Alzheimers Res Ther. 2017 Dec 1;9(1):90. doi: 10.1186/s13195-017-0317-z.
10
Parkin deletion causes cerebral and systemic amyloidosis in human mutated tau over-expressing mice.在人突变tau蛋白过表达小鼠中,帕金森蛋白缺失会导致脑和全身淀粉样变性。
Hum Mol Genet. 2008 Oct 15;17(20):3128-43. doi: 10.1093/hmg/ddn210. Epub 2008 Jul 17.

引用本文的文献

1
Cognitive impairment and p-tau217 are high in a vascular patient cohort.在一个血管病患者队列中,认知障碍和磷酸化tau217水平较高。
Alzheimers Dement. 2025 Aug;21(8):e70565. doi: 10.1002/alz.70565.
2
Cerebral blood flow is associated with plasma and PET biomarkers of tau pathology in middle age.中年人的脑血流量与tau病理学的血浆和PET生物标志物相关。
Brain Commun. 2025 Jun 19;7(4):fcaf249. doi: 10.1093/braincomms/fcaf249. eCollection 2025.
3
Choroidal evaluation of FTLD-Tau and biomarker-determined Alzheimer's disease.额颞叶痴呆- Tau蛋白病和生物标志物确定的阿尔茨海默病的脉络膜评估

本文引用的文献

1
Cerebral Microvascular Accumulation of Tau Oligomers in Alzheimer's Disease and Related Tauopathies.阿尔茨海默病及相关tau蛋白病中tau蛋白寡聚体的脑微血管蓄积
Aging Dis. 2017 May 2;8(3):257-266. doi: 10.14336/AD.2017.0112. eCollection 2017 May.
2
Enhanced Tau Aggregation in the Presence of Amyloid β.在β淀粉样蛋白存在的情况下tau蛋白聚集增强。
Am J Pathol. 2017 Jul;187(7):1601-1612. doi: 10.1016/j.ajpath.2017.03.011. Epub 2017 May 10.
3
Modulation of BDNF cleavage by plasminogen-activator inhibitor-1 contributes to Alzheimer's neuropathology and cognitive deficits.
Sci Rep. 2025 Jul 1;15(1):22290. doi: 10.1038/s41598-025-02020-z.
4
Astrocyte-driven vasoconstriction impairs glymphatic clearance in a human tauopathy-on-chip model.在人源tau蛋白病芯片模型中,星形胶质细胞驱动的血管收缩会损害类淋巴系统清除功能。
APL Bioeng. 2025 Jun 16;9(2):026126. doi: 10.1063/5.0261875. eCollection 2025 Jun.
5
Signs of Alzheimer's Disease: Tied to Aging.阿尔茨海默病的迹象:与衰老相关。
Int J Mol Sci. 2025 May 22;26(11):4974. doi: 10.3390/ijms26114974.
6
Insights into pathophysiology, biomarkers, and therapeutics in tauopathies: Proceedings of the Tau2024 Global Conference.tau蛋白病的病理生理学、生物标志物及治疗方法洞察:2024年tau蛋白病全球会议论文集
Alzheimers Dement. 2025 May;21(5):e70078. doi: 10.1002/alz.70078.
7
Depth-dependent contributions of various vascular zones to cerebral autoregulation and functional hyperemia: An in-silico analysis.不同血管区域对脑自动调节和功能性充血的深度依赖性贡献:一项计算机模拟分析。
PLoS One. 2025 May 19;20(5):e0321053. doi: 10.1371/journal.pone.0321053. eCollection 2025.
8
Roles of neuroimaging markers and biomarkers in cerebral small vessel disease and their associations with cognitive function.神经影像学标志物和生物标志物在脑小血管病中的作用及其与认知功能的关联。
Front Neurol. 2025 May 1;16:1483842. doi: 10.3389/fneur.2025.1483842. eCollection 2025.
9
Risk factors and clinical significance of neurodegenerative co-pathologies in symptomatic cerebral small vessel disease.有症状的脑小血管病中神经退行性共病的危险因素及临床意义。
J Neurol. 2025 Apr 18;272(5):349. doi: 10.1007/s00415-025-13087-z.
10
Fibrillar tau alters cerebral endothelial cell metabolism, vascular inflammatory activation, and barrier function in vitro and in vivo.纤维状tau蛋白在体外和体内均会改变脑内皮细胞代谢、血管炎症激活及屏障功能。
Alzheimers Dement. 2025 Mar;21(3):e70077. doi: 10.1002/alz.70077.
纤溶酶原激活物抑制剂-1 对脑源性神经营养因子剪切的调节作用导致阿尔茨海默病的神经病理学和认知缺陷。
Biochim Biophys Acta Mol Basis Dis. 2017 Apr;1863(4):991-1001. doi: 10.1016/j.bbadis.2017.01.023. Epub 2017 Jan 26.
4
Small vessel disease burden in cerebral amyloid angiopathy without symptomatic hemorrhage.无症状性出血的脑淀粉样血管病中的小血管疾病负担
Neurology. 2017 Feb 28;88(9):878-884. doi: 10.1212/WNL.0000000000003655. Epub 2017 Jan 27.
5
Tau neuropathology correlates with FDG-PET, but not AV-1451-PET, in progressive supranuclear palsy.在进行性核上性麻痹中,tau神经病理学与氟代脱氧葡萄糖正电子发射断层扫描(FDG-PET)相关,但与1-(6-(2-(4-氨基苯基)乙基)氨基)-3,5-二氟-2-(1H-吲哚-3-基)吡啶二盐酸盐正电子发射断层扫描(AV-1451-PET)不相关。
Acta Neuropathol. 2017 Jan;133(1):149-151. doi: 10.1007/s00401-016-1650-1. Epub 2016 Nov 29.
6
Human tau increases amyloid β plaque size but not amyloid β-mediated synapse loss in a novel mouse model of Alzheimer's disease.在一种新型阿尔茨海默病小鼠模型中,人tau蛋白会增加β淀粉样蛋白斑块大小,但不会增加β淀粉样蛋白介导的突触损失。
Eur J Neurosci. 2016 Dec;44(12):3056-3066. doi: 10.1111/ejn.13442. Epub 2016 Nov 12.
7
Matrix metalloproteinases in the brain and blood-brain barrier: Versatile breakers and makers.大脑和血脑屏障中的基质金属蛋白酶:多功能的破坏者与塑造者
J Cereb Blood Flow Metab. 2016 Sep;36(9):1481-507. doi: 10.1177/0271678X16655551. Epub 2016 Jun 20.
8
Do glia drive synaptic and cognitive impairment in disease?神经胶质细胞会引发疾病中的突触和认知障碍吗?
Nat Neurosci. 2015 Nov;18(11):1539-1545. doi: 10.1038/nn.4142. Epub 2015 Oct 27.
9
Transcriptomics Profiling of Alzheimer's Disease Reveal Neurovascular Defects, Altered Amyloid-β Homeostasis, and Deregulated Expression of Long Noncoding RNAs.阿尔茨海默病的转录组学分析揭示神经血管缺陷、淀粉样β蛋白稳态改变以及长链非编码RNA表达失调
J Alzheimers Dis. 2015;48(3):647-65. doi: 10.3233/JAD-150398.
10
IV and IP administration of rhodamine in visualization of WBC-BBB interactions in cerebral vessels.静脉注射和腹腔注射若丹明用于观察脑血管中白细胞与血脑屏障的相互作用。
Microsc Res Tech. 2015 Oct;78(10):894-9. doi: 10.1002/jemt.22552. Epub 2015 Jul 24.